Altimmune (ALT) Revenue (2010 - 2025)

Altimmune (ALT) posted quarterly Revenue of $26000.0 for Q4 2025, up 420.0% year-over-year from $5000.0 in Q4 2024, and up 420.0% quarter-over-quarter from $5000.0 in Q3 2025.

Altimmune (ALT) Revenue (2010 - 2025) Analysis & Trends

Altimmune (ALT) has reported Revenue for 16 consecutive years, with $26000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Revenue rose 420.0% year-over-year to $26000.0; the TTM figure through Dec 2025 stood at $41000.0 (up 105.0% YoY), while the FY2025 annual figure was $41000.0, up 105.0% from the prior year.
  • Revenue advanced to $26000.0 in Q4 2025 per ALT's latest filing, from $5000.0 in the prior quarter.
  • Across five years, Revenue topped out at $3.3 million in Q4 2021 and bottomed at $2000.0 in Q3 2022.
  • Historically, Revenue has averaged $248250.0 across 5 years, with a median of $14500.0 in 2022.
  • Annual changes were most pronounced in 2022 — Revenue tumbled 99.21% — and 2023, when it jumped 18000.0%.
  • Altimmune's Revenue stood at $3.3 million in 2021, then sank by 99.21% to $26000.0 in 2022, then surged by 42.31% to $37000.0 in 2023, then slumped by 86.49% to $5000.0 in 2024, then soared by 420.0% to $26000.0 in 2025.
  • Business Quant data shows ALT's Revenue at $26000.0 in Q4 2025, $5000.0 in Q3 2025, and $5000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.56 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.71 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3,001.92
7 Royalty Pharma 33.72 Bn 35.84 Bn - 674.14 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.29 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 425.49 Mn
10 Altimmune 571.75 Mn 571.75 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 26,000.00
Sep 30, 2025 5,000.00
Jun 30, 2025 5,000.00
Mar 31, 2025 5,000.00
Dec 31, 2024 5,000.00
Sep 30, 2024 5,000.00
Jun 30, 2024 5,000.00
Mar 31, 2024 5,000.00
Dec 31, 2023 37,000.00
Sep 30, 2023 362,000.00
Jun 30, 2023 6,000.00
Mar 31, 2023 21,000.00
Dec 31, 2022 26,000.00
Sep 30, 2022 2,000.00
Jun 30, 2022 8,000.00
Mar 31, 2022 32,000.00
Dec 31, 2021 3.28 Mn
Sep 30, 2021 158,000.00
Jun 30, 2021 137,000.00
Mar 31, 2021 838,000.00